MBX · NASDAQ
MBX Biosciences (MBX) Stock Price & Fundamentals
MBX Biosciences (MBX) closed at $446.75 on Oct 9, 2026, down 0.65% from the previous close of $449.68.
Share price, past year
1Y +12.59%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $446.75 |
| Sep 30, 2026 | $450.99 |
| Aug 31, 2026 | $438.99 |
| Jul 31, 2026 | $408.59 |
| Jun 30, 2026 | $422.97 |
| May 29, 2026 | $391.59 |
| Apr 30, 2026 | $386.83 |
| Mar 31, 2026 | $383.11 |
| Feb 27, 2026 | $383.78 |
| Jan 30, 2026 | $394.81 |
| Dec 31, 2025 | $432.61 |
| Nov 28, 2025 | $392.67 |
| Oct 31, 2025 | $390.76 |
Key statistics
- Market cap
- $21.42B
- EPS (TTM)
- −$2.37
- Net income (TTM)
- −$104.32M
- Shares outstanding
- 47.9M
- 52-week range
- $368.93 – $458.09
MBX Biosciences's market cap is $21.42B, based on a share price of $446.75 and 47.9M shares outstanding as of Jun 30, 2026.
Financials
MBX Biosciences's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
MBX Biosciences reported a net loss of $87.00M in fiscal 2025.
Company profile
- Name
- MBX Biosciences, Inc.
- Ticker
- MBX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 11711 N. Meridian Street, Suite 300, Carmel, IN 46032
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001776111
Recent SEC filings
- Aug 27, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 13, 2026
- Jun 12, 2026
- Jun 5, 2026
- May 11, 2026
- May 7, 2026
Frequently asked questions
What is MBX Biosciences's stock price?
MBX Biosciences (MBX) closed at $446.75 on Oct 9, 2026, down 0.65% from the previous close of $449.68.
What is MBX Biosciences's market cap?
MBX Biosciences's market cap is $21.42B, based on a share price of $446.75 and 47.9M shares outstanding as of Jun 30, 2026.
Does MBX Biosciences pay a dividend?
MBX Biosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from MBX Biosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures